Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BIVI NASDAQ:ELAB NASDAQ:GELS NASDAQ:IMCC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBIVIBioVie$1.63+2.8%$5.48$1.42▼$75.00$12.24M0.66106,245 shs222,813 shsELABPMGC$4.86+4.3%$7.29$4.57▼$1,837.50$7.21M0.17428,064 shs27,346 shsGELSGelteq$1.17-2.9%$1.63$0.77▼$5.50$11.00MN/A1.16 million shs6,368 shsIMCCIM Cannabis$2.33+5.0%$2.75$1.29▼$7.12$12.23M2.19111,633 shs1,943 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBIVIBioVie+3.95%0.00%-73.80%-85.50%-94.32%ELABPMGC+187.65%-34.41%-31.72%-39.75%-99.64%GELSGelteq-4.15%-6.25%-25.93%-29.41%+119,999,900.00%IMCCIM Cannabis-4.31%-0.89%-12.25%-19.27%-9.02%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBIVIBioVie0.5386 of 5 stars0.03.00.00.02.40.00.6ELABPMGC0.7737 of 5 stars0.04.00.00.02.50.00.6GELSGelteqN/AN/AN/AN/AN/AN/AN/AN/AIMCCIM Cannabis0.394 of 5 stars0.03.00.00.03.00.00.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBIVIBioVie 4.00Strong BuyN/AN/AELABPMGC 0.00N/AN/AN/AGELSGelteq 0.00N/AN/AN/AIMCCIM Cannabis 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBIVIBioVieN/AN/AN/AN/A$2.52 per shareN/AELABPMGC$1.71M4.21N/AN/A$6.09 per share0.80GELSGelteq$100K109.98N/AN/A$1.30 per share0.90IMCCIM Cannabis$39.44M0.31N/AN/A$0.56 per share4.16Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBIVIBioVie-$17.54M-$79.10N/A∞N/AN/A-89.02%-75.32%9/29/2025 (Estimated)ELABPMGC-$6.25M-$433.87N/A∞N/AN/A-62.73%-52.83%N/AGELSGelteq-$2.33MN/A0.00∞N/AN/AN/AN/AN/AIMCCIM Cannabis-$7.72M-$0.54N/AN/AN/A-4.19%-59.80%-5.15%11/12/2025 (Estimated)Latest ELAB, GELS, IMCC, and BIVI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025IMCCIM Cannabis-$0.1367-$0.0653+$0.0714-$0.07$12.88 million$9.21 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBIVIBioVieN/AN/AN/AN/AN/AELABPMGCN/AN/AN/AN/AN/AGELSGelteqN/AN/AN/AN/AN/AIMCCIM CannabisN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBIVIBioVieN/A9.109.10ELABPMGCN/A22.4022.40GELSGelteqN/A0.79N/AIMCCIM Cannabis0.320.720.62Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBIVIBioVie4.59%ELABPMGC22.22%GELSGelteqN/AIMCCIM Cannabis7.68%Insider OwnershipCompanyInsider OwnershipBIVIBioVie2.39%ELABPMGC0.24%GELSGelteqN/AIMCCIM CannabisN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBIVIBioVie107.53 million7.35 millionNo DataELABPMGC181.48 million1.48 millionN/AGELSGelteqN/A9.44 millionN/AN/AIMCCIM Cannabis3405.25 millionN/ANot OptionableELAB, GELS, IMCC, and BIVI HeadlinesRecent News About These CompaniesIM Cannabis files to sell 4.98M common shares for holdersAugust 14, 2025 | msn.comIM Cannabis Announces Warrant Amendments and Resale Registration FilingAugust 14, 2025 | msn.comIM Cannabis Announces Warrant Amendments and Form F-3 Resale Registration Statement FilingAugust 13, 2025 | prnewswire.comIM Cannabis Reports Second Quarter 2025 Financial ResultsAugust 12, 2025 | prnewswire.comIM Cannabis to Report Second Quarter 2025 Financial Results on Tuesday, August 12th at 9:00am ETAugust 4, 2025 | prnewswire.comIM Cannabis Closes Private Placement for Gross Proceeds of Approximately US$4.1 MillionJuly 31, 2025 | prnewswire.comIM CANNABIS ANNOUNCES FILING OF SHELF REGISTRATION STATEMENT ON FORM F-3July 11, 2025 | prnewswire.comIM Cannabis Announces the Signing of a Loan Agreement and Appointment of Oz Adler to Board of DirectorsJuly 9, 2025 | prnewswire.comIM Cannabis Provides Corporate UpdatesJuly 1, 2025 | prnewswire.comIM Cannabis (NASDAQ:IMCC) Stock, Earnings Estimates, EPS, And RevenueJune 1, 2025 | benzinga.comIM Cannabis Stock Price, Quotes and Forecasts | NASDAQ:IMCC | BenzingaJune 1, 2025 | benzinga.comCSE Bulletin: Delist - IM Cannabis Corp. (IMCC)May 28, 2025 | newsfilecorp.comNIM Cannabis Corp.: IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities ExchangeMay 28, 2025 | finanznachrichten.deIM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities ExchangeMay 28, 2025 | prnewswire.comIM Cannabis Provides Corporate UpdatesMay 27, 2025 | prnewswire.comIM Cannabis Corp. (IMCC) Q1 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comIM Cannabis Reports First Quarter Financial ResultsMay 15, 2025 | prnewswire.comIM Cannabis Announces Filing of Information Circular for Upcoming Annual General and Special Meeting and Provides Additional Information on the Focus TransactionMay 7, 2025 | prnewswire.comIM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15th at 9:00am ETMay 6, 2025 | prnewswire.comIM Cannabis Provides Corporate UpdatesApril 11, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeELAB, GELS, IMCC, and BIVI Company DescriptionsBioVie NASDAQ:BIVI$1.62 +0.05 (+2.85%) As of 10:19 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease, as well as Phase 2 clinical trial for the treatment of Parkinson's disease. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.PMGC NASDAQ:ELAB$4.86 +0.20 (+4.29%) As of 10:20 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.Gelteq NASDAQ:GELS$1.16 -0.04 (-2.92%) As of 10:02 AM EasternGelteq Inc. is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition. Gelteq Inc. is based in NEW YORK.IM Cannabis NASDAQ:IMCC$2.33 +0.11 (+4.95%) As of 10:17 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CrowdStrike Tests $412 Support as Options Traders Turn Bullish What to Expect From the Q3 Reporting Season Loop Industries Insiders Buy Stock, Signal Confidence in Outlook Joby Aviation's Pullback: A Gift for Investors Who See the Future Kohl’s Stock Rebound Faces a Showdown With Short Sellers Tesla Bulls Need to Tread Very Carefully Right Now Amazon Faces Rare Downgrade—Is the Rally at Risk? What to Watch for From D-Wave Now That Earnings Are Done Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
